The annual Biomedical HIV Prevention Summit, organized by NMAC, opens today in New Orleans and runs through Dec. 5. The Summit brings together community leaders, care providers, and HIV advocates to learn the latest information and best practices to use biomedical HIV prevention tools like Treatment as Prevention (TasP) and Pre-Exposure Prophylaxis (PrEP) more effectively. For a full program of USCA events, activities, and speakers, visit the Summit website.
“NMAC started the Summit as a way to bring more attention to biomedical methods of HIV prevention and to share information and best practices on how to use them,” said NMAC Executive Director Paul Kawata. “Areas that have readily adopted them have started to see significant reductions in new HIV diagnoses. However, we still see great racial disparities in which communities are using tools like PrEP. Since communities of color are disproportionately affected by HIV, we must ensure that those communities have access to these tools and use them.”
The Summit is supported by Presenting Sponsor Gilead; Champion Sponsor ViiV Healthcare; Benefactor Sponsors Janssen and Houston Health Department; Supporters Texas Health Action-Kind Clinic, Walgreen’s, and Washington State Department of Health; and Ally Sponsors Avita Pharmacy and Planned Parenthood.
